CU22413A1 - Antitumorigenic composition - Google Patents
Antitumorigenic compositionInfo
- Publication number
- CU22413A1 CU22413A1 CU1994004A CU1994004A CU22413A1 CU 22413 A1 CU22413 A1 CU 22413A1 CU 1994004 A CU1994004 A CU 1994004A CU 1994004 A CU1994004 A CU 1994004A CU 22413 A1 CU22413 A1 CU 22413A1
- Authority
- CU
- Cuba
- Prior art keywords
- activity
- protease
- type
- alacran
- baee
- Prior art date
Links
- 230000002622 anti-tumorigenesis Effects 0.000 title 1
- 108091005804 Peptidases Proteins 0.000 abstract 3
- 239000004365 Protease Substances 0.000 abstract 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 235000009233 Stachytarpheta cayennensis Nutrition 0.000 abstract 2
- 240000003186 Stachytarpheta cayennensis Species 0.000 abstract 2
- YQDHCCVUYCIGSW-LBPRGKRZSA-N ethyl (2s)-2-benzamido-5-(diaminomethylideneamino)pentanoate Chemical compound NC(=N)NCCC[C@@H](C(=O)OCC)NC(=O)C1=CC=CC=C1 YQDHCCVUYCIGSW-LBPRGKRZSA-N 0.000 abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract 1
- 235000018417 cysteine Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002949 hemolytic effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
- 230000001367 phospholipasic effect Effects 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000002797 proteolythic effect Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
ESTA INVENCION SE RELACIONA CON LAS RAMAS DE LA SALUD HUMANA Y ANIMAL, PARA EL TRATAMIENTO DE VARIOS TIPOS DE NEOPLASIAS. EL OBJETIVO TECNICO DE DICHA SOLUCION ES OBTENER UN PREPARADO FARMACEUTICO A PARTIR DEL ALACRAN (RHOPALURUA JUNCEUS) QUE PRESENTA EFECTO ANTITUMORAL. LA ESENCIA DE LA INVENCION RADICA EN LA PREPARACION DE UN PRODUCTO FARMACEUTICO A PARTIR DEL ALACRAN, QUE TIENE ENTRE SUS COMPONENTES: CONCENTRACION DE PROTEINAS; ACTIVIDAD PROTEOLITICA: ACIDA, NEUTRAL, Y ALCALINA (NEGATIVA): ACTIVIDAD INHIBIDORA DE PROTEASAS: FRENTE A PROTEASA DEL TIPO SERINO 18 UNIDADES BAEE.ML-1; FRENTE A PROTEASA DEL TIPO CISTEINO: 4 UNIDADES BAEE.ML-1; ACTIVIDAD FOSFOLIPASICA TIPO A2: 1, 0,15A10-3; ACTIVIDAD HEMOLITICA (NEGATIVA). DICHO PRODUCTO PUEDE APLICARSE EN LA ESFERA DE LA ELABORACION DE MEDICAMENTOS PARA EL TRATAMIENTO DE DIFERENTES TIPOS DE NEOPLASIAS.\!THIS INVENTION IS RELATED TO THE BRANCHES OF HUMAN AND ANIMAL HEALTH, FOR THE TREATMENT OF SEVERAL TYPES OF NEOPLASMS. THE TECHNICAL OBJECTIVE OF SUCH SOLUTION IS TO OBTAIN A PHARMACEUTICAL PREPARATION FROM THE ALACRAN (RHOPALURUA JUNCEUS) THAT PRESENTS ANTI-TUMORAL EFFECT. THE ESSENCE OF THE INVENTION IS IN THE PREPARATION OF A PHARMACEUTICAL PRODUCT FROM ALACRAN, WHICH HAS BETWEEN ITS COMPONENTS: PROTEIN CONCENTRATION; PROTEOLYTIC ACTIVITY: ACID, NEUTRAL, AND ALKALINE (NEGATIVE): PROTEASE INHIBITING ACTIVITY: AGAINST SERINE TYPE PROTEASE 18 UNITS BAEE.ML-1; IN FRONT OF PROTEASE OF THE CYSTEINE TYPE: 4 UNITS BAEE.ML-1; PHOSPHOLIPASIC ACTIVITY TYPE A2: 1, 0.15A10-3; HEMOLYTIC ACTIVITY (NEGATIVE). SUCH PRODUCT MAY BE APPLIED IN THE FIELD OF PREPARING MEDICINES FOR THE TREATMENT OF DIFFERENT TYPES OF NEOPLASMS. \!
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU1994004A CU22413A1 (en) | 1994-01-11 | 1994-01-11 | Antitumorigenic composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU1994004A CU22413A1 (en) | 1994-01-11 | 1994-01-11 | Antitumorigenic composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU22413A1 true CU22413A1 (en) | 1996-01-31 |
Family
ID=5459147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU1994004A CU22413A1 (en) | 1994-01-11 | 1994-01-11 | Antitumorigenic composition |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU22413A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012041261A2 (en) | 2010-09-27 | 2012-04-05 | Grupo Empresarial De Producciones Biofarmaceuticas Y Quimicas | Peptides from the venom of the rhopalurus junceus scorpion and pharmaceutical composition |
-
1994
- 1994-01-11 CU CU1994004A patent/CU22413A1/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012041261A2 (en) | 2010-09-27 | 2012-04-05 | Grupo Empresarial De Producciones Biofarmaceuticas Y Quimicas | Peptides from the venom of the rhopalurus junceus scorpion and pharmaceutical composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69836822D1 (en) | Process for the treatment of capsules and dry powdered pharmaceutical formulations | |
| ES2155473T3 (en) | VETERINARY COMPOSITION CONTAINING A PROTON PUMP INHIBITOR. | |
| DE602004016729D1 (en) | 1-PHENYLALKANCARBONIC ACID DERIVATIVES FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES | |
| CN105671018A (en) | Eggshell membrane solubilization method using enzymes | |
| ES2190653T3 (en) | Reaction products of hyaluronic acid and amino NATURAL and their use in cosmetic and pharmaceutical compositions. | |
| BG105588A (en) | Anthranilic acide amides and the use thereof as medicaments | |
| DE602004016403D1 (en) | Topical pharmaceutical compositions containing active natural ingredients for the prevention and treatment of mucosal inflammatory processes | |
| FR2453650A1 (en) | MEDICAMENT BASED ON CHOLECALCIFEROL DERIVATIVES, USEFUL FOR ADJUSTING BONE METABOLISM IN HOMEOTHERMES | |
| EP1604659A4 (en) | COMPRESSOR CONTAINING AN AMINO ACID ABSORBING WATER | |
| ATE340561T1 (en) | USE OF ANTISEPTICS FOR THE PRODUCTION OF MEDICINAL PRODUCTS FOR THE PROPHYLAXIS AND TREATMENT OF INFLAMMATION INSIDE THE HUMAN BODY | |
| CN103463967A (en) | Special-purpose formaldehyde scavenging agent for air purifier | |
| BRPI0408299A (en) | cathepsin inhibitors s | |
| TR200100637T2 (en) | New natural product derivatives | |
| MY126358A (en) | Compositions comprising vx478 and a water soluble tocopherol derivative such as vitamin e-tpgs | |
| CU22413A1 (en) | Antitumorigenic composition | |
| ES2187030T3 (en) | A NEW SALT | |
| CU22414A1 (en) | Fungicide composition | |
| AU6011001A (en) | Novel lhrh-antagonists, production and use thereof as medicament | |
| ATE390121T1 (en) | MICELLE COMPOSITIONS CONTAINING PEGYLATED PHOSPHOLIPIDES AND A PHOTOSENSITISER | |
| ID26240A (en) | FORMULATION OF SOLID HALF DRUGS CONTAINING TROMETAMOL DEXSTOPROFENES | |
| ES2175582T3 (en) | CHROMANS SUBSTITUTED WITH SULFONAMIDE, PROCEDURE FOR THEIR PREPARATION, ITS USE AS A MEDICINAL PRODUCT, AS WELL AS PHARMACEUTICAL PREPARATIONS CONTAINING THEM. | |
| ATE255890T1 (en) | PANTOTHENIC ACID CONTAINING MEDICINAL PRODUCTS FOR THE TREATMENT OF INFLAMMATORY JOINT DISEASES | |
| RU2232711C1 (en) | Method of production of xenon difluoride, its rectification and application | |
| AR030945A1 (en) | AMIDAS OF FENILCICLOHEXANOCARBOXILICO SUBSTITUTED ACID AND USE | |
| AR010950A1 (en) | METHODS OF TREATMENT OF DRY AND SPRAY CAPSULES AND PHARMACEUTICAL FORMULATIONS. |